糖尿病病的尿路生物标志物
Guido Gembillo1, Luca Soraci2, Rossella Messina3
1Unit of Nephrology and Dialysis, AOU "G. Martino", University of Messina, Messina 98125, Sicilia, Italy. ggembillo@gmail.com.
World journal of diabetes
|January 29, 2026
概括
尿路生物标志物对糖尿病病 (DKD) 的早期检测和个性化治疗有希望. 研究强调了白蛋白,损伤分子-1和代谢特征,以改善诊断和患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 生物标志物发现发现
背景情况:
- 糖尿病病 (DKD) 是糖尿病的一个主要并发症,影响生活质量和增加心血管风险.
- 糖尿病的慢性高血糖导致持续的白蛋白尿和功能受损,这是DKD的特征.
- 早期检测和干预对于管理DKD和改善患者结果至关重要.
研究的目的:
- 探索尿路生物标志物的潜力,以早期识别DKD进展.
- 研究各种生物标志物如何改善DKD的诊断,监测和理解.
- 突出生物标志物在风险分层和个性化治疗策略中对DKD患者的作用.
主要方法:
- 审查关于DKD尿路生物标志物的当前研究.
- 分析已经确定的生物标志物,如白蛋白和新兴候选物,如损伤分子-1和中性粒细胞凝酶相关的利波卡林.
- 探索与DKD相关的代谢特征和遗传/表观遗传因素.
主要成果:
- 尿路生物标志物,包括白蛋白,KIM-1和NGAL,为DKD病理生理学和损伤提供了洞察力.
- 代谢特征可以帮助区分DKD与其他脏疾病.
- 遗传和表观遗传因素可能会影响个体对DKD并发症的倾向.
结论:
- 尿路生物标志物具有显著的潜力,可以改善DKD的早期检测,监测和风险分层.
- 了解生物标志物机制可以推动针对DKD的向疗法的开发.
- 将生物标记数据集成到临床实践中可以导致个性化治疗和更好的患者护理.
相关概念视频
Chronic Kidney Disease I: Introduction
725
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
725
Chronic Kidney Disease II: Clinical Manifestations
641
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
641
Chronic Kidney Disease III: Interprofessional Care
466
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
466
Chronic Kidney Disease IV: Nursing Management
388
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
388
Kidney Structure
75.1K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.1K
Pathophysiology of Diabetes
3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K


